Bio-Rad Laboratories, Inc.’s BIO share price has dipped by 5.31%, which has investors questioning if this is right time to ...

Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve cancer outcomes for at-risk ...

The microbiology culture market is projected to grow at a CAGR of ~6% over the forecast period. Major factors driving growth ...

The U.S. Food and Drug Administration announced earlier this month that it will be phasing out animal testing for some new ...

A miniature lab has been launched into Earth orbit containing microbes designed to produce edible proteins in space.Imperial scientists are looking ...

Sanofi signed a deal with Earendil Labs for $125 million upfront and $1.72 billion in milestone payments. Regeneron Pharmaceuticals signed a deal worth more than $3 billion with contract drug ...

As climate change continues to reshape our world, its impact on food safety is becoming a growing concern. One of the most ...

For instance, franchised lab facilities could just as readily support food-testing labs in Vietnam ... speaks with Tomasz Kostrzewski, CSO at CN Bio, about single organ-on-a-chip technology.

Mursla Bio is advancing regulatory compliance for EvoLiver as a Laboratory Developed Test (LDT) in preparation for its upcoming product launch, while also laying the groundwork for future FDA ...

Sponsored by Business Location Switzerland Interview with Christoph Besmer, US Trade Commissioner for Switzerland in the ...